The official blog of the Lung Institute.

What Doctors are Saying About Cellular Therapy


Knowing the state of the field is critical to making the right decision for your health.

Although cellular therapy has come a long way in the treatment of chronic lung diseases like chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (PF) and interstitial lung disease, it’s important to know the opinions of doctors within the field. As a relatively emerging form of treatment for chronic lung disease, the viewpoint of doctors on current cellular therapy methods, and what their opinions are on the future of the field is key.

This is true, not only because they—along with treatment clinics like the Lung Institute—will need to push the field forward to bring the treatment further into the mainstream, but because of patients who’ve run out of options, the confidence of their physicians is an important component in their health decisions.

With your health in mind, the Lung Institute is here to bridge the gap between your current knowledge and what’s being said by experts in the field and help you find out what doctors are saying about cells.

So, What Are Doctors Saying About Cellular Therapy?

Doctor opinions on cellular therapy have typically been mixed—with some being dismissive of the science to others being optimistic for anything that may provide lasting relief for their patients. What is clear from medical professionals in the field across the board is there is a clear applicable potential for the use of cellular therapy as a form of treatment. The Lung Institute collects patient outcomes data to show how patients are being affected by treatment. The Lung Institute has seen great success, but new medical practices take time to become widely accepted. Sometimes, patients do not have time to wait.

“Cellular therapy technologies are reshaping how medicine is practiced in the U.S., yet our traditional way of introducing a medication, instrument or procedure has been found to be too slow, too expensive, too cumbersome and frequently, not applicable to the situation,” said Jack Coleman, M.D., medical director of the Lung Institute.

The scientific field has a broad understanding of what happens within the body on a molecular level once these specialized reparative cells enter the body. They are attracted to areas of the body that are damaged and will spur the release of pericytes and cytokines, which promote internal healing. However, some claim there is still much to learn in order to produce consistent and replicative effects in all patients. This is why it is so important for cellular clinics to collect and study data.

It is important to note there is minimal risk in receiving cellular therapy because the cells are derived from a person’s own body, and are not foreign to it in any way. This reduces negative side effects that are typical of most medications. Because of this, many people facing limited options decide to try cellular therapy, and many have seen an improvement in their quality of life as a result. Furthermore, many primary care doctors who were initially skeptical of treatment are amazed by the results that patients experience after receiving cellular therapy.

The knowledge that is available about cellular therapy is growing, and the Lung Institute partners with and works to educate primary care providers on the benefits of cellular therapy. While it’s important for patients to be able to take their health decisions into their own hands, it’s also important for doctors to be educated in all available treatment options so they may give their patients the most current and viable information

“Our responsibility is to give the best, safest treatment to patients to relieve pain and suffering and prolong quality of life. Our world is getting smaller, knowledge is becoming more egalitarian and medical care is becoming more standardized across nations,” said Dr. Coleman. “At some point, we may realize that healthcare development from bench to bedside needs to progress beyond national sovereignty and become a global effort.”

So, What Can I Do Now?

Luckily, current available treatment options do more than simply address the symptoms.Cellular therapy has the potential to stop the progression of the disease and, in some cases, even improve a person’s condition. Many Lung Institute patients see an improvement in their quality of life after receiving cellular therapy from the Lung Institute.

However, in managing your quality of life, the first step is always to quit smoking,if you haven’t already. The second would be to address your overall health through diet and exercise.

With these behavioral changes, it’s possible to greatly affect the pronouncement of symptoms within those with COPD, emphysema and pulmonary fibrosis. However, when lifestyle changes fail to improve your quality of life in the way you may expect, it may be time to consider cellular therapy. Rather than addressing the symptoms of lung disease, cellular therapy may directly affect disease progression and may improve quality of life.

For more information on cellular therapy and what it could mean for your life moving forward, contact us today or call us at 888-745-6697. Our patient coordinators will walk you through our available treatment options, discuss your current health and medical history and determine a qualifying treatment plan that works best for you.

Interested in our article on What Doctors Are Saying About Cells? Share your thoughts and comments below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.